Jian Hua Mo
Directeur/Membre du Conseil chez HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD
Fortune : 175 M $ au 30/06/2024
Profil
Mr. Jian Hua Mo is a General Manager at Hangzhou Pute Equity Investment Management Ltd.
and an Executive Director & General Manager at Hangzhou Binpu Real Estate Development Ltd.
He is on the Board of Directors at Binjiang Service Group Co. Ltd., Hangzhou Binjiang Real Estate Group Co., Ltd., Shanghai Binshun Investment Management Ltd and Hangzhou Binpu Real Estate Development Ltd.
Mr. Mo was previously employed as a General Manager by Hangzhou Binjiang Venture Captal Investment Ltd.
and a Deputy General Manager by Hangzhou Binjiang Real Estate Construction Co. Ltd.
He also served on the board at Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
He received his MBA from Zhejiang University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 75 195 600 ( 17,52% ) | 75 M $ | 30/06/2024 | |
| 30/06/2023 | 35 640 000 ( 12,89% ) | 75 M $ | 30/06/2024 | |
| 30/09/2023 | 25 065 200 ( 0,93% ) | 25 M $ | 30/06/2024 |
Postes actifs de Jian Hua Mo
| Sociétés | Poste | Début |
|---|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Directeur/Membre du Conseil | 01/05/2012 |
| BINJIANG SERVICE GROUP CO. LTD. | Directeur/Membre du Conseil | 01/12/2017 |
| Shanghai Binshun Investment Management Ltd | Directeur/Membre du Conseil | - |
| Hangzhou Binpu Real Estate Development Ltd. | Directeur/Membre du Conseil | - |
| Hangzhou Pute Equity Investment Management Ltd. | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Jian Hua Mo
| Sociétés | Poste | Fin |
|---|---|---|
| Hangzhou Binjiang Venture Captal Investment Ltd. | Corporate Officer/Principal | 01/11/2017 |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. | Corporate Officer/Principal | 01/12/1999 |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Directeur/Membre du Conseil | - |
Formation de Jian Hua Mo
| Zhejiang University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| HANGZHOU BINJIANG REAL ESTATE GROUP CO.,LTD | Finance |
| BINJIANG SERVICE GROUP CO. LTD. | Finance |
| Entreprise privées | 6 |
|---|---|
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Health Technology |
| Shanghai Binshun Investment Management Ltd | |
| Hangzhou Binpu Real Estate Development Ltd. | |
| Hangzhou Pute Equity Investment Management Ltd. | |
| Hangzhou Binjiang Venture Captal Investment Ltd. | |
| Hangzhou Binjiang Real Estate Construction Co. Ltd. |
